Greenrose Acquisition Corp. Announces Closing of Business Combination with Theraplant
Greenrose to Continue Trading on the OTC Under Ticker Symbol “GNRS”AMITYVILLE, N.Y., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Greenrose Acquisition...
News
Celsion Corporation Invited to Present Poster at Cytokine-Based Cancer Immunotherapies Summit
Celsion Corporation’s GEN-1 IL-12 Program in Advanced Ovarian Cancer to be Featured in Poster Presentation Chief Science Officer Dr. Khursheed...
Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update
$26.8 Million in Cash and Marketable Securities as of November 15, 2021, Expected to Support Operations Well Into 2023SOLANA BEACH,...
SCYNEXIS to Host Ibrexafungerp Hospital Pipeline Update Call and KOL Webcast for Investors on December 6
JERSEY CITY, N.J., Nov. 29, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome...
BioCryst Begins Patient Enrollment in REDEEM-2 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
RESEARCH TRIANGLE PARK, N.C., Nov. 29, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the enrollment of...
Simply Better Brands Corp. Announces Third Quarter 2021 Results
VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. ("SBBC" or the "Company") (TSX Venture: SBBC,...
TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China
First Approval of a Subcutaneously Administered Checkpoint Inhibitor TRACON’s Pivotal U.S. Trial for Envafolimab in Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma...
ExCellThera announces data to be presented at the American Society of Hematology 2021 annual meeting
MONTRÉAL, Nov. 29, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell expansion and engineering company delivering molecules and bioengineering...
Ceapro Inc. Announces R&D Funding to Support PGX Technology Project
– PGX Technology further recognized as a disruptive technology – Additional support paves the way for the manufacturing of pharmaceutical-grade...
Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System
Proven CleanCap® reagent technology from TriLink BioTechnologies delivers significant time and cost savings for mRNA-based vaccine and therapeutic applicationsCodex DNA...
Salarius Pharmaceuticals to Participate in Annual Benchmark Company Discovery One-on-One Conference
HOUSTON, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines...
Brooklyn ImmunoTherapeutics Welcomes Susan McClatchey as Vice President and Head of Quality
Company Continues to Secure Resources to Build Gene Editing/Cell Therapy Drug Development PlatformNEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) --...
Piezo Motion and iMotion Inc. Announce Partnership
Piezo Motion’s new partnership with iMotion will expand Piezo’s precision motor technologies and motion control offerings to the Rocky Mountain...
F-star Therapeutics to Host Virtual R&D Day on December 6, 2021
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical...
Athenex Announces UK MHRA Validation of the Marketing Authorization Application for Oral Paclitaxel and Encequidar for Review
BUFFALO, N.Y., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
USA Equities Corp. Introduces AllergiQT™ – Quick Test, Further Expanding Market Presence
FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary...
Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion Criteria
Amendment aligns eligibility for Tigris with current clinical practice in septic shock Potential to improve Tigris enrollment rates by 25%...
Ultragenyx Announces Additional Positive Multi-Year Durability Data from Phase 1/2 AAV Gene Therapy Studies
NOVATO, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
BetterLife Successfully Completes Phase 1 and Initiates Phase 2 Clinical Trials with Interferon Alpha-2b in COVID-19 Patients in Chile
VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today...
Vor to Participate in the JMP Securities Hematology and Oncology Summit
CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today...
